Related references
Note: Only part of the references are listed.Scaling up prevention and treatment towards the elimination of hepatitis C: a global mathematical model
Alastair Heffernan et al.
LANCET (2019)
Global Elimination of Chronic Hepatitis
David L. Thomas
NEW ENGLAND JOURNAL OF MEDICINE (2019)
GALAD Score for Hepatocellular Carcinoma Detection in Comparison with Liver Ultrasound and Proposal of GALADUS Score
Ju Dong Yang et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2019)
Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next-Generation Sequencing for Matching Patients to Targeted and Immune Therapies
James J. Harding et al.
CLINICAL CANCER RESEARCH (2019)
Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study
Amit G. Singal et al.
GASTROENTEROLOGY (2019)
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Andrew X. Zhu et al.
LANCET ONCOLOGY (2019)
AASLD guidelines for the treatment of hepatocellular carcinoma
Julie K. Heimbach et al.
HEPATOLOGY (2018)
Clinical outcomes of stereotactic body radiotherapy for elderly patients with hepatocellular carcinoma
Yuji Teraoka et al.
HEPATOLOGY RESEARCH (2018)
A systematic review of publications on charged particle therapy for hepatocellular carcinoma
Hiroshi Igaki et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2018)
Management of Hepatocellular Carcinoma in Japan as a World-Leading Model
Masatoshi Kudo
LIVER CANCER (2018)
Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis
An Tang et al.
ABDOMINAL RADIOLOGY (2018)
Tobacco, alcohol use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The Liver Cancer Pooling Project
Jessica L. Petrick et al.
BRITISH JOURNAL OF CANCER (2018)
Excellent Outcomes of Liver Transplantation Following Down-Staging of Hepatocellular Carcinoma to Within Milan Criteria: A Multicenter Study
Neil Mehta et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs
Pierre Nahon et al.
GASTROENTEROLOGY (2018)
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Jorge A. Marrero et al.
HEPATOLOGY (2018)
Herbal medicine containing aristolochic acid and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection
Chi-Jen Chen et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Stereotactic Body Radiation Therapy as an Alternative to Transarterial Chemoembolization for Hepatocellular Carcinoma
Eli Sapir et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma
Pierce K. H. Chow et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Masatoshi Kudo et al.
LANCET (2018)
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
Andrew X. Zhu et al.
LANCET ONCOLOGY (2018)
Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B
G. Jourdain et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
G. K. Abou-Alfa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Evidence Supporting LI-RADS Major Features for CT- and MR Imaging-based Diagnosis of Hepatocellular Carcinoma: A Systematic Review
An Tang et al.
RADIOLOGY (2018)
Percutaneous Ablation for Hepatocellular Carcinoma: Comparison of Various Ablation Techniques and Surgery
Shuichiro Shiina et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)
Microwave vs radiofrequency ablation for hepatocellular carcinoma within the Milan criteria: a propensity score analysis
Wenwu Liu et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Percutaneous ablation for perivascular hepatocellular carcinoma: Refining the current status based on emerging evidence and future perspectives
Tae Wook Kang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Metabolic Risk Factors Are Associated With Non-Hepatitis B Non-Hepatitis C Hepatocellular Carcinoma in Taiwan, an Endemic Area of Chronic Hepatitis B
Shiu-Feng Huang et al.
HEPATOLOGY COMMUNICATIONS (2018)
Efficacy of microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma in patients with chronic liver disease: a randomised controlled phase 2 trial
Naik Vietti Violi et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2018)
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon
S. Petta et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Impact of Country of Birth on Age at the Time of Diagnosis of Hepatocellular Carcinoma in the United States
Ju Dong Yang et al.
CANCER (2017)
Percutaneous cooled-probe microwave versus radiofrequency ablation in early-stage hepatocellular carcinoma: a phase III randomised controlled trial
Jie Yu et al.
GUT (2017)
An Assessment of Benefits and Harms of Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis
Omair Atiq et al.
HEPATOLOGY (2017)
Coffee and the risk of hepatocellular carcinoma and chronic liver disease: a systematic review and meta-analysis of prospective studies
Francesca Bravi et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2017)
Microwave ablation for the treatment of hepatocellular carcinoma that met up-to-seven criteria: feasibility, local efficacy and long-term outcomes
Yun Xu et al.
EUROPEAN RADIOLOGY (2017)
Unusually High Rates of Hepatocellular Carcinoma After Treatment With Direct-Acting Antiviral Therapy for Hepatitis C Related Cirrhosis
Sujan Ravi et al.
GASTROENTEROLOGY (2017)
Association of Provider Specialty and Multidisciplinary Care With Hepatocellular Carcinoma Treatment and Mortality
Marina Serper et al.
GASTROENTEROLOGY (2017)
Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents
Fasiha Kanwal et al.
GASTROENTEROLOGY (2017)
Radiofrequency Ablation of Hepatocellular Carcinoma as Bridge Therapy to Liver Transplantation: A 10-Year Intention-to-Treat Analysis
Min Woo Lee et al.
HEPATOLOGY (2017)
Hepatocellular carcinoma in the absence of cirrhosis in patients with chronic hepatitis B virus infection
Maneerat Chayanupatkul et al.
JOURNAL OF HEPATOLOGY (2017)
Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification
Julien Calderaro et al.
JOURNAL OF HEPATOLOGY (2017)
Stereotactic body radiotherapy vs. TACE or RFA as a bridge to transplant in patients with hepatocellular carcinoma. An intention-to-treat analysis
Gonzalo Sapisochin et al.
JOURNAL OF HEPATOLOGY (2017)
Feasibility and Diagnostic Accuracy of Point-of-Care Abdominal Sonography by Pocket-Sized Imaging Devices, Performed by Medical Residents
Ingunn E. Kjesbu et al.
JOURNAL OF ULTRASOUND IN MEDICINE (2017)
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
Jordi Bruix et al.
LANCET (2017)
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
Anthony B. El-Khoueiry et al.
LANCET (2017)
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial
Valerie Vilgrain et al.
LANCET ONCOLOGY (2017)
Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia
Alvin W. T. Ng et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Overdiagnosis: An Understudied Issue in Hepatocellular Carcinoma Surveillance
Nicole E. Rich et al.
SEMINARS IN LIVER DISEASE (2017)
Consensus on Stereotactic Body Radiation Therapy for Small-Sized Hepatocellular Carcinoma at the 7th Asia-Pacific Primary Liver Cancer Expert Meeting
Zhao-Chong Zeng et al.
LIVER CANCER (2017)
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015 A Systematic Analysis for the Global Burden of Disease Study
Christina Fitzmaurice et al.
JAMA ONCOLOGY (2017)
Improved Performance of Serum Alpha-Fetoprotein for Hepatocellular Carcinoma Diagnosis in HCV Cirrhosis with Normal Alanine Transaminase
Ju Dong Yang et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)
Survival benefit of liver resection for Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma
H. Kim et al.
BRITISH JOURNAL OF SURGERY (2017)
Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma
Adrian Ally et al.
CELL (2017)
Validation of the Hong Kong Liver Cancer Staging System in Determining Prognosis of the North American Patients Following Intra-arterial Therapy
Jae Ho Sohn et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2017)
Hepatocellular Carcinoma Is the Most Common Indication for Liver Transplantation and Placement on the Waitlist in the United States
Ju Dong Yang et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2017)
Weight Loss Decreases Magnetic Resonance Elastography Estimated Liver Stiffness in Nonalcoholic Fatty Liver Disease
Niraj S. Patel et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2017)
Risk of hepatocellular carcinoma among individuals with different aetiologies of cirrhosis: a population-based cohort study
J. West et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Palliative interventions for hepatocellular carcinoma patients: analysis of the National Cancer Database
Abdulrahman Y. Hammad et al.
ANNALS OF PALLIATIVE MEDICINE (2017)
Long-term outcomes of proton beam therapy in patients with previously untreated hepatocellular carcinoma
Kuniaki Fukuda et al.
CANCER SCIENCE (2017)
Characteristics, management, and outcomes of patients with hepatocellular carcinoma in Africa: a multicountry observational study from the Africa Liver Cancer Consortium
Ju Dong Yang et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
Application of the Intermediate-Stage Subclassification to Patients With Untreated Hepatocellular Carcinoma
Edoardo G. Giannini et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)
Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis
Ju Dong Yang et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)
Unresectable Hepatocellular Carcinoma: Radioembolization Versus Chemoembolization: A Systematic Review and Meta-analysis
Laila Lobo et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2016)
Cryoablation of Hepatocellular Carcinoma with High-Risk for Percutaneous Ablation: Safety and Efficacy
Gyoung Min Kim et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2016)
Improved Detection of Hepatocellular Carcinoma by Using a Longitudinal Alpha-Fetoprotein Screening Algorithm
Nabihah Tayob et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans Is Associated With Nonalcoholic Fatty Liver Disease
Sahil Mittal et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients
Sarah Berhane et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Mutational signature of aristolochic acid: Clue to the recognition of a global disease
Thomas A. Rosenquist et al.
DNA REPAIR (2016)
Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma
Riad Salem et al.
GASTROENTEROLOGY (2016)
Long-term Effects of Hepatitis B Immunization of Infants in Preventing Liver Cancer
Mei-Hwei Chang et al.
GASTROENTEROLOGY (2016)
The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Lipiodol Transarterial Chemoembolization for Hepatocellular Carcinoma: A Systematic Review of Efficacy and Safety Data
Riccardo Lencioni et al.
HEPATOLOGY (2016)
Risk of Hepatocellular Carcinoma After Sustained Virological Response in Veterans With Hepatitis C Virus Infection
Hashem B. El-Serag et al.
HEPATOLOGY (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Prospective Validation of Ab Initio Liver Transplantation in Hepatocellular Carcinoma Upon Detection of Risk Factors for Recurrence After Resection
Joana Ferrer-Fabrega et al.
HEPATOLOGY (2016)
Randomized Clinical Trial Comparing Proton Beam Radiation Therapy with Transarterial Chemoembolization for Hepatocellular Carcinoma: Results of an Interim Analysis
David A. Bush et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone
Karen T. Brown et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
Theodore S. Hong et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Future of Hepatocellular Carcinoma Incidence in the United States Forecast Through 2030
Jessica L. Petrick et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals
Fabio Conti et al.
JOURNAL OF HEPATOLOGY (2016)
Validation of the Hong Kong liver cancer staging system in hepatocellular carcinoma patients treated with curative intent
Lily Wu et al.
JOURNAL OF HEPATOLOGY (2016)
Direct acting antiviral therapy and tumor recurrence after liver transplantation for hepatitis C-associated hepatocellular carcinoma
Ju Dong Yang et al.
JOURNAL OF HEPATOLOGY (2016)
PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy
George Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2016)
Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial
Riccardo Lencioni et al.
JOURNAL OF HEPATOLOGY (2016)
Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy
Maria Reig et al.
JOURNAL OF HEPATOLOGY (2016)
Lack of evidence of an effect of direct-acting antivirals on the recurrence of hepatocellular carcinoma: Data from three ANRS cohorts
JOURNAL OF HEPATOLOGY (2016)
Proposed New Sub-Grouping for intermediate-Stage Hepatotceliular Carcinoma Using Albumin-Bilirubin Grade
Atsushi Hiraoka et al.
ONCOLOGY (2016)
Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma
Fabio Farinati et al.
PLOS MEDICINE (2016)
Percutaneous cryoablation of hepatic tumors: long-term experience of a large US series
Peter J. Littrup et al.
ABDOMINAL RADIOLOGY (2016)
Hepatocellular Carcinoma Occurs at an Earlier Age in Africans, Particularly in Association With Chronic Hepatitis B
Ju Dong Yang et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Alpha-Fetoprotein Measurement Benefits Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis
Te-Sheng Chang et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Recurrence of Hepatocellular Cancer After Resection Patterns, Treatments, and Prognosis
Parissa Tabrizian et al.
ANNALS OF SURGERY (2015)
Impact of Long-Term Tenofovir Disoproxil Fumarate on Incidence of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
W. Ray Kim et al.
CANCER (2015)
The role of hepatic resection in the treatment of hepatocellular cancer
Sasan Roayaie et al.
HEPATOLOGY (2015)
Association of Nonalcoholic Fatty Liver Disease (NAFLD) with Hepatocellular Carcinoma (HCC) in the United States From 2004 to 2009
Zobair M. Younossi et al.
HEPATOLOGY (2015)
Portal Hypertension and the Outcome of Surgery for Hepatocellular Carcinoma in Compensated Cirrhosis: A Systematic Review and Meta-analysis
Annalisa Berzigotti et al.
HEPATOLOGY (2015)
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach-The ALBI Grade
Philip J. Johnson et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
Jordi Bruix et al.
LANCET ONCOLOGY (2015)
A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study
Xue-Jia Lin et al.
LANCET ONCOLOGY (2015)
Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study
Joong-Won Park et al.
LIVER INTERNATIONAL (2015)
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
Kornelius Schulze et al.
NATURE GENETICS (2015)
Transition from millennium development goals to sustainable development goals and hepatitis
Yasir Waheed
PATHOGENS AND GLOBAL HEALTH (2015)
Integration of tumour and viral genomic characterisations in HBV-related hepatocellular carcinomas
Giuliana Amaddeo et al.
GUT (2015)
LI-RADS (Liver Imaging Reporting and Data System): Summary, Discussion, and Consensus of the LI-RADS Management Working Group and Future Directions
Donald G. Mitchell et al.
HEPATOLOGY (2015)
The Detection of Hepatocellular Carcinoma Using a Prospectively Developed and Validated Model Based on Serological Biomarkers
Philip J. Johnson et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)
Development of Hong Kong Liver Cancer Staging System With Treatment Stratification for Patients With Hepatocellular Carcinoma
Thomas Yau et al.
GASTROENTEROLOGY (2014)
A New Laboratory-Based Algorithm to Predict Development of Hepatocellular Carcinoma in Patients With Hepatitis C and Cirrhosis
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2014)
Mechanisms underlying mutational signatures in human cancers
Thomas Helleday et al.
NATURE REVIEWS GENETICS (2014)
Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis
Amit G. Singal et al.
PLOS MEDICINE (2014)
Palliative external-beam radiotherapy for bone metastases from hepatocellular carcinoma
Shinya Hayashi et al.
WORLD JOURNAL OF HEPATOLOGY (2014)
Population-Attributable Fractions of Risk Factors for Hepatocellular Carcinoma in the United States
Tania M. Welzel et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Reduced Aflatoxin Exposure Presages Decline in Liver Cancer Mortality in an Endemic Region of China
Jian-Guo Chen et al.
CANCER PREVENTION RESEARCH (2013)
Annual Incidence of Hepatocellular Carcinoma Among Patients With Alcoholic Cirrhosis and Identification of Risk Groups
Alejo Mancebo et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Statins Are Associated With a Reduced Risk of Hepatocellular Cancer: A Systematic Review and Meta-analysis
Siddharth Singh et al.
GASTROENTEROLOGY (2013)
Yttrium-90 Radioembolization for Intermediate-Advanced Hepatocellular Carcinoma: A Phase 2 Study
Vincenzo Mazzaferro et al.
HEPATOLOGY (2013)
Obesity: An epidemiological perspective from Asia and its relationship to gastrointestinal and liver cancers
Li-Yen Goh et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
Epidemiology and natural history of HCV infection
Behzad Hajarizadeh et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Hepatitis C Virus Testing of Persons Born During 1945-1965: Recommendations From the Centers for Disease Control and Prevention
Bryce D. Smith et al.
ANNALS OF INTERNAL MEDICINE (2012)
Risk for Hepatocellular Carcinoma in Patients With Alcoholic Cirrhosis A Danish Nationwide Cohort Study
Peter Jepsen et al.
ANNALS OF INTERNAL MEDICINE (2012)
Hepatic venous pressure gradient in the assessment of portal hypertension before liver resection in patients with cirrhosis
E. Boleslawski et al.
BRITISH JOURNAL OF SURGERY (2012)
Chemoembolization With Doxorubicin-Eluting Beads for Unresectable Hepatocellular Carcinoma: Five-Year Survival Analysis
Katerina Malagari et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2012)
Population attributable risk of aflatoxin-related liver cancer: Systematic review and meta-analysis
Yan Liu et al.
EUROPEAN JOURNAL OF CANCER (2012)
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
Hashem B. El-Serag
GASTROENTEROLOGY (2012)
Identification of osteopontin as a novel marker for early hepatocellular carcinoma
Sufen Shang et al.
HEPATOLOGY (2012)
Model to estimate survival in ambulatory patients with hepatocellular carcinoma
Ju Dong Yang et al.
HEPATOLOGY (2012)
Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis
Adriaan J. van der Meer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma
Kai Feng et al.
JOURNAL OF HEPATOLOGY (2012)
Nonsteroidal Anti-inflammatory Drug Use, Chronic Liver Disease, and Hepatocellular Carcinoma
Vikrant V. Sahasrabuddhe et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Radioembolization Results in Longer Time-to-Progression and Reduced Toxicity Compared With Chemoembolization in Patients With Hepatocellular Carcinoma
Riad Salem et al.
GASTROENTEROLOGY (2011)
Ultrasonographic Surveillance of Hepatocellular Carcinoma in Cirrhosis: A Randomized Trial Comparing 3-and 6-Month Periodicities
Jean-Claude Trinchet et al.
HEPATOLOGY (2011)
Feasibility of Conducting a Randomized Control Trial for Liver Cancer Screening: Is a Randomized Controlled Trial for Liver Cancer Screening Feasible or Still Needed?
Hossein Poustchi et al.
HEPATOLOGY (2011)
Survival After Yttrium-90 Resin Microsphere Radioembolization of Hepatocellular Carcinoma Across Barcelona Clinic Liver Cancer Stages: A European Evaluation
Bruno Sangro et al.
HEPATOLOGY (2011)
A Randomized Trial Comparing Radiofrequency Ablation and Surgical Resection for HCC Conforming to the Milan Criteria
Jiwei Huang et al.
ANNALS OF SURGERY (2010)
Therapeutic Equivalence in Survival for Hepatic Arterial Chemoembolization and Yttrium 90 Microsphere Treatments in Unresectable Hepatocellular Carcinoma A Two-Cohort Study
Brian I. Carr et al.
CANCER (2010)
Des-γ-Carboxy Prothrombin and α-Fetoprotein as Biomarkers for the Early Detection of Hepatocellular Carcinoma
Anna S. Lok et al.
GASTROENTEROLOGY (2010)
Phase I Pharmacologic and Biologic Study of Ramucirumab (IMC-1121B), a Fully Human Immunoglobulin G1 Monoclonal Antibody Targeting the Vascular Endothelial Growth Factor Receptor-2
Jennifer L. Spratlin et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival
Valentina Santi et al.
JOURNAL OF HEPATOLOGY (2010)
Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: A systematic review
George V. Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2010)
Hepatocellular carcinoma: a global view
Ju Dong Yang et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2010)
The aflatoxin-induced TP53 mutation at codon 249 (R249S): Biomarker of exposure, early detection and target for therapy
Doriane Gouas et al.
CANCER LETTERS (2009)
Integrative Transcriptome Analysis Reveals Common Molecular Subclasses of Human Hepatocellular Carcinoma
Yujin Hoshida et al.
CANCER RESEARCH (2009)
α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular Carcinoma
Jorge A. Marrero et al.
GASTROENTEROLOGY (2009)
Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005
Sean F. Altekruse et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
Vincenzo Mazzaferro et al.
LANCET ONCOLOGY (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: An intention-to-treat analysis
Francis Y. Yao et al.
HEPATOLOGY (2008)
Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation
Lijian Hui et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Curbing the liver cancer epidemic in Africa
Pierre Hainaut et al.
LANCET (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
Yujin Hoshida et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Prescription profile of potentially aristolochic acid containing Chinese herbal products: an analysis of National Health Insurance data in Taiwan between 1997 and 2003
Shu-Ching Hsieh et al.
Chinese Medicine (2008)
Safety and efficacy of Y-90 radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis
Laura M. Kulik et al.
HEPATOLOGY (2008)
Liver transplantation for hepatocellular carcinoma: Validation of the UCSF-Expanded criteria based on preoperative imaging
F. Y. Yao et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2007)
Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets
Sandrine Boyault et al.
HEPATOLOGY (2007)
Staging hepatocellular carcinoma by a novel scoring system (BALAD score) based on serum markers
Hidenori Toyoda et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Radiation therapy for hepatocellular carcinoma - From palliation to cure
MA Hawkins et al.
CANCER (2006)
The association between diabetes and hepatocellular carcinoma: A systematic review of epidemiologic evidence
HB El-Serag et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma
MS Chen et al.
ANNALS OF SURGERY (2006)
A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation
FY Yao et al.
LIVER TRANSPLANTATION (2005)
Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of end-stage liver disease (MELD) score predicts perioperative mortality
SH Teh et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2005)
Reduction in exposure to carcinogenic aflatoxins by postharvest intervention measures in west Africa: a community-based intervention study
PC Turner et al.
LANCET (2005)
Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score compared with the CLIP score
M Kudo et al.
HEPATOLOGY (2004)
Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis
MC Kew
LIVER INTERNATIONAL (2003)
A central role for JNK in obesity and insulin resistance
J Hirosumi et al.
NATURE (2002)
Liver transplantation for hepatocellular carcinoma: Comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria
FY Yao et al.
LIVER TRANSPLANTATION (2002)
Aristolochic acid as a probable human cancer hazard in herbal remedies: a review
VM Arlt et al.
MUTAGENESIS (2002)
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma:: a randomised controlled trial
JM Llovet et al.
LANCET (2002)
Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma
CM Lo et al.
HEPATOLOGY (2002)
Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival
FY Yao et al.
HEPATOLOGY (2001)
Inflammation and cancer: back to Virchow?
F Balkwill et al.
LANCET (2001)
Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: A 16-year population-based study
BJ McMahon et al.
HEPATOLOGY (2000)
Share Paper
